Search research articles
Contact Us
Filters
Showing results (71-80 of 147) with videos related to
Page
of 15
Sort By:
Oncotarget
|
October 6, 2017
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience
Yuan Yuan, Susan E Yost, John Yim, et al.
Oncotarget
|
January 7, 2017
Genomic mutation-driven metastatic breast cancer therapy: a single center experience
Yuan Yuan, Susan E Yost, John Yim, et al.
Journal of Cell Science
|
April 26, 2014
A crucial role for DOK1 in PDGF-BB-stimulated glioma cell invasion through p130Cas and Rap1 signalling
Angela Barrett, Ian M Evans, Antonina Frolov, et al.
Leukemia & Lymphoma
|
February 20, 2016
A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study
Mark H Kirschbaum, Paul Frankel, Timothy W Synold, et al.
Neuro-Oncology Advances
|
January 6, 2022
Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
Ryan T Woodall, Prativa Sahoo, Yujie Cui, et al.
Journal of Biomedical Optics
|
June 30, 2019
Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors
Paul Yazaki, Thinzar Lwin, Megan Minnix, et al.
Journal of Cancer Research and Clinical Oncology
|
May 18, 2007
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium
Kim Margolin, Timothy W Synold, Primo Lara, et al.
Haematologica
|
January 18, 2015
A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
Robert Chen, Paul Frankel, Leslie Popplewell, et al.
Breast (Edinburgh, Scotland)
|
December 4, 2014
Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab
Arvind M Shinde, Jing Zhai, Kim Wai Yu, et al.
Oncotarget
|
November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
May Cho, Jun Gong, Paul Frankel, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 147) with videos related to
Sort By:
Page
of 15
Oncotarget
|
October 6, 2017
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience
Yuan Yuan, Susan E Yost, John Yim, et al.
Oncotarget
|
January 7, 2017
Genomic mutation-driven metastatic breast cancer therapy: a single center experience
Yuan Yuan, Susan E Yost, John Yim, et al.
Journal of Cell Science
|
April 26, 2014
A crucial role for DOK1 in PDGF-BB-stimulated glioma cell invasion through p130Cas and Rap1 signalling
Angela Barrett, Ian M Evans, Antonina Frolov, et al.
Leukemia & Lymphoma
|
February 20, 2016
A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study
Mark H Kirschbaum, Paul Frankel, Timothy W Synold, et al.
Neuro-Oncology Advances
|
January 6, 2022
Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
Ryan T Woodall, Prativa Sahoo, Yujie Cui, et al.
Journal of Biomedical Optics
|
June 30, 2019
Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors
Paul Yazaki, Thinzar Lwin, Megan Minnix, et al.
Journal of Cancer Research and Clinical Oncology
|
May 18, 2007
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium
Kim Margolin, Timothy W Synold, Primo Lara, et al.
Haematologica
|
January 18, 2015
A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
Robert Chen, Paul Frankel, Leslie Popplewell, et al.
Breast (Edinburgh, Scotland)
|
December 4, 2014
Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab
Arvind M Shinde, Jing Zhai, Kim Wai Yu, et al.
Oncotarget
|
November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
May Cho, Jun Gong, Paul Frankel, et al.
Page
of 15